Sana Biotechnology, Inc.
NASDAQ:SANA
4.29 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 137.349 | 176.765 | 253.029 | 411.995 | 80.03 | 30.63 |
| Short Term Investments
| 71.678 | 247.198 | 297.967 | 253.458 | 58.952 | 0 |
| Cash and Short Term Investments
| 209.027 | 434.014 | 746.877 | 411.995 | 138.982 | 30.63 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.488 | 14.374 | 7.105 | 6.203 | 5.281 | 1.966 |
| Total Current Assets
| 213.515 | 444.437 | 558.101 | 384.467 | 144.263 | 32.596 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 145.592 | 159.403 | 161.784 | 109.943 | 69.314 | 0.585 |
| Goodwill
| 140.627 | 140.627 | 140.627 | 140.627 | 140.627 | 0 |
| Intangible Assets
| 59.195 | 59.195 | 59.195 | 59.195 | 59.195 | 0 |
| Goodwill and Intangible Assets
| 199.822 | 199.822 | 199.822 | 199.822 | 199.822 | 0 |
| Long Term Investments
| 0 | 10.051 | 195.881 | 33.731 | 1.777 | 0.816 |
| Tax Assets
| 0 | 0 | 0 | 0 | -1.777 | 0 |
| Other Non-Current Assets
| 6.37 | 9.007 | 13.819 | 2.333 | 2.299 | 0.336 |
| Total Non-Current Assets
| 351.784 | 378.283 | 571.306 | 345.829 | 271.435 | 1.737 |
| Total Assets
| 565.299 | 822.72 | 1,129.407 | 730.296 | 415.698 | 34.333 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.108 | 2.857 | 2.219 | 2.253 | 0 | 0.289 |
| Short Term Debt
| 13.195 | 12.393 | 9.159 | 3.712 | 1.848 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 31.475 | 0 | 0 | 0 |
| Other Current Liabilities
| 47.184 | 96.254 | 56.382 | 25.486 | 17.981 | 1.496 |
| Total Current Liabilities
| 64.487 | 111.504 | 99.235 | 31.451 | 19.829 | 1.785 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 90.901 | 95.86 | 101.784 | 68.197 | 46.359 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 122.405 | 116.041 | 199.886 | 1,051.832 | 492.052 | 45.736 |
| Total Non-Current Liabilities
| 213.306 | 211.901 | 301.67 | 1,120.029 | 538.411 | 45.736 |
| Total Liabilities
| 277.793 | 323.405 | 400.905 | 1,151.48 | 558.24 | 47.521 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 1,129.407 | 852.897 | 417.359 | 45.721 |
| Common Stock
| 0.02 | 0.019 | 0.018 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -1,338.091 | -1,054.836 | -785.36 | -429.432 | -144.127 | -13.247 |
| Accumulated Other Comprehensive Income/Loss
| -0.06 | -4.327 | -1.366 | 0.03 | 0.026 | -45.722 |
| Other Total Stockholders Equity
| 1,625.637 | 1,558.459 | 385.803 | -844.681 | -415.801 | 0.059 |
| Total Shareholders Equity
| 287.506 | 499.315 | 728.502 | -421.184 | -142.542 | -13.188 |
| Total Equity
| 287.506 | 499.315 | 728.502 | -421.184 | -142.542 | -13.188 |
| Total Liabilities & Shareholders Equity
| 565.299 | 822.72 | 1,129.407 | 730.296 | 415.698 | 34.333 |